Home › Non-Small Cell Lung Cancer › Illinois › Carbondale
Non-Small Cell Lung Cancer clinical trials in Carbondale, IL
5 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Carbondale (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- SIH Cancer Institute, Carterville · 8 mi away
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
RecruitingPhase 2
- Memorial Hospital of Carbondale, Carbondale
- SIH Cancer Institute, Carterville · 8 mi away
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
RecruitingPhase 3
- Clinical Study Site, Carterville · 8 mi away
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- SIH Cancer Institute, Carterville · 8 mi away
GEMINI-NSCLC: NSCLC Biomarker Study
RecruitingObservational study
- Southern Illinois Hospital Services, Carterville · 8 mi away
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Other studies in Carbondale
- Colorectal Cancer7 studies
- Breast Cancer6 studies
- Colon Cancer4 studies
- Lung Cancer4 studies
- Prostate Cancer3 studies
- Pancreatic Cancer3 studies
- Cancer (all types)3 studies
- Melanoma3 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.